Latest Transformation News

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in FSGS kidney disease has passed its seventh Independent Data Monitoring Committee review with no safety concerns, reinforcing the drug’s promising safety profile.

Horizon Oil Limited reported robust FY25 results, highlighted by a strategic acquisition of Thailand upstream assets and a 10-year permit extension at Maari, nearly doubling production and securing a strong outlook through 2030.

BCAL Diagnostics is preparing to launch its Avantect® pancreatic and ovarian cancer blood tests in Australia by January 2026, following key regulatory approvals and promising clinical data. The company also broadens the reach of its BREASTESTplus™ breast cancer test, targeting a larger segment of women with dense breast tissue.

Decidr AI Industries has announced a strategic acquisition of Delaware-based Sugarwork Inc., marking its official entry into the US market and enhancing its Agentic AI platform with advanced knowledge transfer capabilities.

Cyclopharm Limited reaffirms its ambitious target of 250–300 US Technegas installations by late 2026, driven by FDA approval, CMS reimbursement, and a growing pipeline of healthcare sites. The company reports record half-year revenue growth, signaling strong momentum in the expanding lung imaging market.

EVE Health Group has partnered with telehealth provider hubMed to deliver a national patient support program, enhancing care continuity for users of its Dyspro and Libbo therapies.

Nuix Limited’s 2025 AGM revealed steady ACV growth, a leadership transition, and a strategic push centered on its Nuix Neo platform to fuel future expansion.

Lark Distilling Co. Ltd reported a 12% increase in FY25 revenue to $15.6 million, bolstered by a strategic partnership with Seppeltsfield Wines and a successful brand restage. The company also announced a leadership change with a new CEO set to take the helm in January 2026.

Aquirian Limited is accelerating its growth trajectory through strategic joint ventures and a major expansion of its Wubin facility, aiming to reshape the mining services landscape with advanced drill and blast technologies.

Nufarm reported a mixed FY25 with strong crop protection profits offset by a statutory loss from seed restructuring, while targeting earnings growth and debt reduction in FY26.

KMD Brands reported a challenging FY25 with a net loss but has launched a transformative ‘Next Level’ strategy focused on cost reset, product innovation, and digital growth. Early FY26 trading shows promising sales momentum, signaling potential turnaround.

KMD Brands reports a solid 7.9% increase in first quarter sales, driven by strong Kathmandu and Rip Curl performances, while managing inventory and margin pressures ahead of key seasonal trading.